Moreover, by employing siRNA transfection techniques to knock down Fos expression in the CT26 cell line, they found that the downregulation of Fos reduced the proliferation of mouse colorectal cancer cells by approximately 20%, and survival analysis indicated that mice with low Fos expression exhibited better survival outcomes. The gene discussed is FOS; the disease is colorectal cancer.